论文部分内容阅读
Chronic hepatitis B （CHB） remains a significant unmetmedical need, with 240 million chronically infectedpersons worldwide. It can be controlled effectivelywith either nucleoside/nucleotide-based or interferonbasedtherapies. However, most patients receivin